Status: Ongoing, but not recruiting participants.
ClinicalTrials.gov Identifier: NCT02484690
BP29647: A Phase III, Multi-Center, Multi-Dose, Double-Masked, Parallel Group to investigate the Safety and Tolerability of RO6867461 in patients with Choroidal Neovascularization Secondary to Age-related Macular Degeneration.
Condition: Choroidal Neovascularization
Study Type: Interventional
Duration: 36 weeks
For additional information on this study, please click hereBack to Clinical Research